Research library
Grade CRegistered trial2028n=27

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

Yale University

ClinicalTrials.gov, 2028-06-01

Plain English summary

This clinical study investigates whether having a family history of psychosis is linked to differences in the body's cannabinoid system. Researchers are administering THC as a pharmacological probe to compare physiological and psychological responses between individuals with and without a family history of psychosis.

Outcome

Outcome is pending as this trial is currently active and results have not yet been published.

Abstract

Conditions: Psychosis, Cannabis Use, THC, Marijuana, Schizophrenia Status: ACTIVE_NOT_RECRUITING Enrolment: 27 The overall purpose of this study is to determine whether a family history of psychosis is associated with an altered cannabinoid system. This will be tested by studying individuals with and without a family history of psychosis and comparing their responses to delta 9-tetrahydrocannabinol (THC), a probe of the cannabinoid system. We hypothesize, that compared to controls with no family history of psychoses, individuals with a family history of psychoses will have an altered response to THC.

Conditions

psychosisschizophrenia

Cannabinoids

THC

Body systems

Summary generated automatically from the published abstract for educational purposes. Not medical advice. Always consult the original source and a qualified clinician.